Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

Roche told investors on Monday that it plans to make significant cuts to both the cost and time it takes for it to develop ...

Demand forweight-loss drugs has grown at an astonishing rate in recent years, driving share prices of healthcare giants such ...

The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...

U.S. representative from Austin asks Health and Human Services secretary to push for generic licensing of semaglutide ...

The new weight-loss drugs were originally developed as a treatment for type ... While a tablet form of semaglutide is already available, this was initially approved as a low-dose version that is less ...

In this article, we will discuss: 12 Best Growth Stocks To Buy According To Hedge Funds.

By Kenneth P. Vogel and Susanne Craig Zelensky Meets Trump Amid Fears for Continued U.S. Support for Ukraine The session in New York was part of a nearly weeklong U.S. visit by the Ukrainian ...

Welcome to the Loss, Trauma, and Emotion Lab, headed by Professor George A Bonanno. Our offices are housed in the Department of Counseling and Clinical Psychology, Teachers College, Columbia ...